Latest News and Press Releases
Want to stay updated on the latest news?
-
OTTAWA, May 04, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V:TBP) (OTCQB:TBPMF), and Azevedos Indústria Farmacêutica, S.A. announced that they have signed a...
-
OTTAWA, ONTARIO--(Marketwired - April 24, 2018) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP) (OTCQB:TBPMF), announced today that the Company has signed a first...
-
OTTAWA, ONTARIO--(Marketwired - April 12, 2018) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP) (OTCQB:TBPMF), provides a status report on its encapsulated cannabis...
-
OTTAWA, ONTARIO--(Marketwired - April 10, 2018) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development...
-
OTTAWA, ONTARIO--(Marketwired - April 4, 2018) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP) (OTCQB:TBPMF), today announced the initiation of screening and...
-
OTTAWA, ONTARIO--(Marketwired - April 3, 2018) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), today announced the appointment of Guy Chamberland,...
-
OTTAWA, ONTARIO--(Marketwired - March 27, 2018) - This document corrects and replaces the press release that was sent on March 27, 2018 at 7:30 PM ET. Tetra Bio-Pharma Inc....
-
OTTAWA, ONTARIO--(Marketwired - March 27, 2018) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development...
-
OTTAWA, ONTARIO--(Marketwired - March 20, 2018) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development...
-
OTTAWA, ONTARIO--(Marketwired - March 19, 2018) - Tetra Bio-Pharma Inc. ("Tetra" or the "Corporation") (TSX VENTURE:TBP)(OTCQB:TBPMF), today announced the completion of the previously...